Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication used for the short-term management of anxiety disorders, insomnia, and status epilepticus. It acts as a central nervous system depressant.
## Primary Indications
* **Anxiety Disorders:** Short-term relief of anxiety symptoms.
* **Insomnia:** Short-term management of sleep difficulties.
* **Status Epilepticus:** Treatment of prolonged seizures.
* **Preoperative Sedation:** To reduce anxiety and provide amnesia prior to medical procedures.
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally 2 to 3 times daily. Maximum daily dose typically 10 mg.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Preoperative Sedation:** 2 mg to 4 mg intramuscularly or intravenously 1 to 2 hours before surgery.
* **Status Epilepticus:** 4 mg intravenously, repeated once after 10 to 15 minutes if needed. (Local protocol often dictates specific dosing and adjunctive therapies).
## Pediatric Dosing
* **Anxiety/Sedation:** Dosing is highly variable and depends on age, weight, and indication. Specific pediatric guidelines should be consulted. For example, some sources suggest 0.02 mg/kg to 0.06 mg/kg orally or intramuscularly every 4 to 6 hours as needed, not to exceed adult doses.
* **Status Epilepticus:** 0.1 mg/kg intravenously, not to exceed 4 mg per dose. May be repeated once after 10 to 15 minutes. (Consult specific pediatric status epilepticus protocols).
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary due to decreased metabolism.
* **Renal Impairment:** Generally does not require dose adjustment unless severe impairment.
## Contraindications
* Known hypersensitivity to benzodiazepines or their components.
* Acute angle-closure glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, ataxia, sedation, confusion.
Less Common: Paradoxical excitement, amnesia, visual disturbances, hypotension.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **CYP3A4 Inhibitors/Inducers:** May alter lorazepam metabolism, though lorazepam is less susceptible than some other benzodiazepines due to glucuronidation.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Level of sedation and respiratory rate.
* Signs of dependence and withdrawal with prolonged use.
* Mental status and cognitive function.
* Signs and symptoms of paradoxical reactions.
## Clinical Pearls
* Lorazepam has an intermediate half-life compared to other benzodiazepines.
* Intravenous administration for status epilepticus should be given slowly to avoid respiratory depression and hypotension.
* Avoid abrupt discontinuation due to risk of withdrawal symptoms. Taper dose gradually.
* Use the lowest effective dose for the shortest duration necessary.
* Concurrent use with opioids significantly increases the risk of adverse outcomes.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines before making any treatment decisions.
